drugset / Trial / NCT00392587

A Study To Investigate The Effects Of GW856553 On Patients With COPD (Chronic Obstructive Pulmonary Disease)

NCT00392587

Phase 2 Completed 30 enrolled GlaxoSmithKline
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to assess the safety of GW856553 in COPD patients and to assess its affects on their COPD disease after 14 days.

Timeline

Start
2006-08
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Losmapimod Small molecule Oral